Publicacións (22) Publicacións de FRANCISCO MORENO RAMOS

2024

  1. Ceftazidime–Avibactam Use in a Case Series of Difficult-to-Treat or Recurrent Infections in Pediatric Patients with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development

    Antibiotics, Vol. 13, Núm. 7

  2. Incorporation of patient-reported outcomes into pharmacy and dermatology departments, in psoriasis and atopic dermatitis patients, as a tool to improve the healthcare quality and health outcomes

    Journal of Healthcare Quality Research, Vol. 39, Núm. 1, pp. 13-22

  3. Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022

    Anaerobe, Vol. 86

  4. Is it in their eyes? Correlation between microorganisms isolated from bronchial aspirates and conjunctival swabs in a Pediatric Intensive Care Unit

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 176-179

2023

  1. Agreement between pharmacists and physicians on the assessment of appropriateness of antimicrobial prescribing

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

    Antibiotics, Vol. 12, Núm. 3

  3. Dalbavancin as Consolidation Therapy in Elderly Patients

    European Journal of Geriatrics and Gerontology, Vol. 5, Núm. 2, pp. 139-143

  4. Intestinal loads of extended-spectrum beta-lactamase and Carbapenemase genes in critically ill pediatric patients

    Frontiers in Cellular and Infection Microbiology, Vol. 13

2022

  1. Resistance to meropenem-vaborbactam in clinical isolates of Enterobacter roggenkampii without previous exposure to vaborbactam

    Clinical Microbiology and Infection

2021

  1. Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia

    Medical Mycology, Vol. 59, Núm. 4, pp. 350-354

2019

  1. Indicators of the hospital use of antimicrobial agents based on consumption

    Farmacia Hospitalaria, Vol. 43, Núm. 3, pp. 94-100

2018

  1. Lumbar arthrodesis infection by multi-resistant Klebsiella pneumoniae, successfully treated with implant retention and ceftazidime/avibactam

    Revista Espanola de Cirugia Ortopedica y Traumatologia, Vol. 62, Núm. 6, pp. 471-473

  2. Retrospective study assessing the burden of varicella in méxico in children 1-14 years of age treated across 10 sites

    Acta Pediatrica de Mexico, Vol. 39, Núm. 6, pp. 334-348

2017

  1. Identifying priorities to improve paediatric in-hospital antimicrobial use by cross-sectional evaluation of prevalence and appropriateness of prescription

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 35, Núm. 9, pp. 556-562

2016

  1. Opportunities to improve antimicrobial use in paediatric intensive care units: A nationwide survey in Spain

    Clinical Microbiology and Infection, Vol. 22, Núm. 2, pp. 171-177

2013

  1. Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: A major clinical challenge

    Clinical Microbiology and Infection, Vol. 19, Núm. 2

  2. How to assist clinicians in improving antimicrobial prescribing: Tools and interventions provided by stewardship programs

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. SUPPL. 4, pp. 38-44

  3. Infections caused by oxa-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 1, pp. 89-96

  4. Knowledge and perceptions of junior and senior Spanish resident doctors about antibiotic use and resistance: Results of a multicenter survey

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 4, pp. 199-204

2012

  1. Atención farmacéutica en antibioticoterapia: Las 100 primeras consultas

    Atencion Farmaceutica, Vol. 14, Núm. 4, pp. 288-290